Competitive Landscape of Orphan Drugs Market
The Orphan Drugs Market advancement is redefining standards for therapeutic development in ultra-rare indications. Gene therapy vectors, enzyme replacement platforms, and antisense oligonucleotides require rigorous characterization to ensure safety and efficacy. The oral therapies segment is expected to post a 12.82% CAGR through 2035 as formulation science improves bioavailability for rare...
0 Comments 0 Shares 47 Views 0 Reviews